Login Register Cart 0
Generic placeholder image

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5230
ISSN (Online): 1875-614X

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Therapeutic Approach of Probiotics in Children with Atopic Dermatitis

Author(s): Sangeeta Huidrom*

Volume 20, Issue 1, 2021

Published on: 02 January, 2020

Page: [2 - 9] Pages: 8

DOI: 10.2174/1871523019666200102110317

Price: $65

Abstract

Pediatric atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease, affecting 20% of children all over the world especially in developed countries. The global prevalence of AD in children has been increasing over recent years. This chronic inflammatory skin disease causes economic and social burden to the family. The exact cause of AD is not known, however recent studies suggest that the imbalance of microflora present in the gut leads to AD. The current treatment of AD involves the application of moisturizer, topical corticosteroids, antihistamines and antibiotics. This line of treatment of AD in children has many side effects. An alternative novel therapeutic approach has to be explored to combat this chronic skin disease. In recent years, there has been increasing interest in the use of probiotics in the modulation of gut microbiota for the management of AD. Many research studies showed that the administration of probiotics gives positive results in the prevention and treatment of AD in children, however, the results are not consistent and conclusive. In this review, the phenomenon that the dysbiosis of the gut flora contributes to the development of AD is addressed and clinical evidence of probiotics in the prevention and treatment of AD children is also summarised.

Keywords: Atopic dermatitis, dysbiosis, gut microbiota, pediatric, probiotic, microflora.

« Previous
Graphical Abstract

[1]
Lyons, J.J.; Milner, J.D.; Stone, K.D. Atopic dermatitis in children: Clinical features, pathophysiology, and treatment. Immunol. Allergy Clin. North Am., 2015, 35(1), 161-183.
[http://dx.doi.org/10.1016/j.iac.2014.09.008] [PMID: 25459583]
[2]
Willemsen, M.G.; van Valburg, R.W.; Dirven-Meijer, P.C.; Oranje, A.P.; van der Wouden, J.C.; Moed, H. Determining the severity of atopic dermatitis in children presenting in general practice: An easy and fast method. Dermatol. Res. Pract., 2009, 2009, 357046.
[http://dx.doi.org/10.1155/2009/357046 ] [PMID: 20585477]
[3]
Schmid-Grendelmeier, P.; Simon, D.; Simon, H.U.; Akdis, C.A.; Wüthrich, B. Epidemiology, clinical features, and immunology of the “intrinsic” (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). Allergy, 2001, 56(9), 841-849.
[http://dx.doi.org/10.1034/j.1398-9995.2001.00144.x ] [PMID: 11551248]
[4]
Spergel, J.M. From atopic dermatitis to asthma: The atopic march. Ann. Allergy Asthma Immunol., 2010, 105(2), 99-106.
[http://dx.doi.org/10.1016/j.anai.2009.10.002] [PMID: 20674819]
[5]
Williams, H.; Robertson, C.; Stewart, A.; Aït-Khaled, N.; Anabwani, G.; Anderson, R.; Asher, I.; Beasley, R.; Björkstén, B.; Burr, M.; Clayton, T.; Crane, J.; Ellwood, P.; Keil, U.; Lai, C.; Mallol, J.; Martinez, F.; Mitchell, E.; Montefort, S.; Pearce, N.; Shah, J.; Sibbald, B.; Strachan, D.; von Mutius, E.; Weiland, S.K. Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J. Allergy Clin. Immunol., 1999, 103(1 Pt 1), 125-138.
[http://dx.doi.org/10.1016/S0091-6749(99)70536-1] [PMID: 9893196]
[6]
Lambrecht, B.N.; Hammad, H. The immunology of the allergy epidemic and the hygiene hypothesis. Nat. Immunol., 2017, 18(10), 1076-1083.
[http://dx.doi.org/10.1038/ni.3829] [PMID: 28926539]
[7]
Strachan, D.P. Hay fever, hygiene, and household size. BMJ, 1989, 299(6710), 1259-1260.
[http://dx.doi.org/10.1136/bmj.299.6710.1259] [PMID: 2513902]
[8]
Lio, P.A.; Lee, M.; LeBovidge, J.; Timmons, K.G.; Schneider, L. Clinical management of atopic dermatitis: Practical highlights and updates from the atopic dermatitis practice parameter 2012. J. Allergy Clin. Immunol. Pract., 2014, 2(4), 361-369.
[http://dx.doi.org/10.1016/j.jaip.2014.02.015] [PMID: 25017522]
[9]
Sommer, F.; Bäckhed, F. The gut microbiota-masters of host development and physiology. Nat. Rev. Microbiol., 2013, 11(4), 227-238.
[http://dx.doi.org/10.1038/nrmicro2974] [PMID: 23435359]
[10]
Lynch, S.V.; Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med., 2016, 375(24), 2369-2379.
[http://dx.doi.org/10.1056/NEJMra1600266] [PMID: 27974040]
[11]
Noverr, M.C.; Huffnagle, G.B. The ‘microflora hypothesis’ of allergic diseases. Clin. Exp. Allergy,, 2005, 35(12), 1511-1520.
[http://dx.doi.org/10.1111/j.1365-2222.2005.02379.x] [PMID: 16393316]
[12]
Buccigrossi, V.; Nicastro, E.; Guarino, A. Functions of intestinal microflora in children. Curr. Opin. Gastroenterol., 2013, 29(1), 31-38.
[http://dx.doi.org/10.1097/MOG.0b013e32835a3500]]
[13]
Wang, M.; Karlsson, C.; Olsson, C.; Adlerberth, I.; Wold, A.E.; Strachan, D.P.; Martricardi, P.M.; Aberg, N.; Perkin, M.R.; Tripodi, S.; Coates, A.R.; Hesselmar, B.; Saalman, R.; Molin, G.; Ahrné, S. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J. Allergy Clin. Immunol., 2008, 121(1), 129-134.
[http://dx.doi.org/10.1016/j.jaci.2007.09.011] [PMID: 18028995]
[14]
Björkstén, B.; Naaber, P.; Sepp, E.; Mikelsaar, M. The intestinal microflora in allergic estonian and swedish 2-year-old children. Clin. Exp. Allergy, 1999, 29(3), 342-346.
[http://dx.doi.org/10.1046/j.1365-2222.1999.00560.x] [PMID: 10202341]
[15]
Sofia, R. Federica, Del C.; Andrea, Q.; Simona, G.; Pamela, V.; Alessandra R.; Alessandro F.; Paolo R.; Lorenza P.;May, E.H. Gut microbiota profile in children affected by atopic dermatitis and evaluation of intestinal persistence of a probiotic mixture. Sci. Rep., 2019, 9, 4996.
[http://dx.doi.org/10.1038/s41598-019-41149-6]
[16]
Metchnikoff, E. The Prolongation of Life; G P Putnam’s Sons 1910. In Mitchell PC editor: New York, 1910.
[17]
Özdemir, O. Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clin. Exp. Immunol., 2010, 160(3), 295-304.
[http://dx.doi.org/10.1111/j.1365-2249.2010.04109.x PMID: 20345982]
[18]
Viljanen, M.; Kuitunen, M.; Haahtela, T.; Juntunen-Backman, K.; Korpela, R.; Savilahti, E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol., 2005, 16(1), 65-71.
[http://dx.doi.org/10.1111/j.1399-3038.2005.00224.x PMID: 15693914]
[19]
Zheng, J.; Feng, Q.; Zheng, S.; Xiao, X. The effects of probiotics supplementation on metabolic health in pregnant women: An evidence based meta-analysis. PLoS One, 2018, 13(5), e0197771.
[http://dx.doi.org/10.1371/journal.pone.0197771] [PMID: 29782556]
[20]
Majamaa, H.; Isolauri, E. Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immunol., 1997, 99(2), 179-185.
[http://dx.doi.org/10.1016/S0091-6749(97)70093-9] [PMID: 9042042]
[21]
Isolauri, E.; Arvola, T.; Sütas, Y.; Moilanen, E.; Salminen, S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy, 2000, 30(11), 1604-1610.
[http://dx.doi.org/10.1046/j.1365-2222.2000.00943.x] [PMID: 11069570]
[22]
Yeşilova, Y.; Çalka, Ö.; Akdeniz, N.; Berktaş, M. Effect of probiotics on the treatment of children with atopic dermatitis. Ann. Dermatol., 2012, 24(2), 189-193.
[http://dx.doi.org/10.5021/ad.2012.24.2.189] [PMID: 22577270]
[23]
Rosenfeldt, V.; Benfeldt, E.; Valerius, N.H.; Paerregaard, A.; Michaelsen, K.F. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr., 2004, 145(5), 612-616.
[http://dx.doi.org/10.1016/j.jpeds.2004.06.068] [PMID: 15520759]
[24]
Hee, Y.J.; Kim, D.H.; Ku, J.K.; Kang, Y.; Kim, M.Y.; Kim, H.K.; Chung, M.J.; Park, Y.M. Therapeutic effects of probiotics in patients with atopic dermatitis. J. Microbiol. Biotechnol., 2006, 16(11), 1699-1705.
[25]
Weston, S.; Halbert, A.; Richmond, P.; Prescott, S.L. Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch. Dis. Child., 2005, 90(9), 892-897.
[http://dx.doi.org/10.1136/adc.2004.060673] [PMID: 15863468]
[26]
Yang, H.J.; Min, T.K.; Lee, H.W.; Pyun, B.Y. Efficacy of probiotic therapy on atopic dermatitis in children: A randomized, double-blind, placebo-controlled trial. Allergy Asthma Immunol. Res., 2014, 6(3), 208-215.
[http://dx.doi.org/10.4168/aair.2014.6.3.208] [PMID: 24843795]
[27]
Han, Y.; Kim, B.; Ban, J.; Lee, J.; Kim, B.J.; Choi, B.S.; Hwang, S.; Ahn, K.; Kim, J. A randomized trial of Lactobacillus plantarum CJLP133 for the treatment of atopic dermatitis. Pediatr. Allergy Immunol., 2012, 23(7), 667-673.
[http://dx.doi.org/10.1111/pai.12010] [PMID: 23050557]
[28]
Woo, S.I.; Kim, J.Y.; Lee, Y.J.; Kim, N.S.; Hahn, Y.S. Effect of Lactobacillus sakei supplementation in children with atopic eczema-dermatitis syndrome. Ann. Allergy Asthma Immunol., 2010, 104(4), 343-348.
[http://dx.doi.org/10.1016/j.anai.2010.01.020] [PMID: 20408346]
[29]
Navarro-López, V.; Ramírez-Boscá, A.; Ramón-Vidal, D.; Ruzafa-Costas, B.; Genovés-Martínez, S.; Chenoll-Cuadros, E.; Carrión-Gutiérrez, M.; Horga de la Parte, J.; Prieto-Merino, D.; Codoñer-Cortés, F.M. Effect of oral administration of a mixture of probiotic strains on scorad index and use of topical steroids in young patients with moderate atopic dermatitis: A randomized clinical trial. JAMA Dermatol., 2018, 154(1), 37-43.
[http://dx.doi.org/10.1001/jamadermatol.2017.3647 PMID: 29117309]
[30]
Enomoto, T.; Sowa, M.; Nishimori, K.; Shimazu, S.; Yoshida, A.; Yamada, K.; Furukawa, F.; Nakagawa, T.; Yanagisawa, N.; Iwabuchi, N.; Odamaki, T.; Abe, F.; Nakayama, J.; Xiao, J.Z. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol. Int., 2014, 63(4), 575-585.
[http://dx.doi.org/10.2332/allergolint.13-OA-0683] [PMID: 25056226]
[31]
Rautava, S.; Kainonen, E.; Salminen, S.; Isolauri, E. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J. Allergy Clin. Immunol., 2012, 130(6), 1355-1360.
[http://dx.doi.org/10.1016/j.jaci.2012.09.003] [PMID: 23083673]
[32]
Ekaputri, J.; Evalina, R.; Deliana, M. Additional probiotic therapy lowers SCORAD index in children with atopic dermatitis. Universa Medicina, 2016, 35(2), 6.
[33]
Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet, 2001, 357(9262), 1076-1079.
[http://dx.doi.org/10.1016/S0140-6736(00)04259-8 PMID: 11297958]
[34]
Kalliomäki, M.; Salminen, S.; Poussa, T.; Arvilommi, H.; Isolauri, E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet, 2003, 361(9372), 1869-1871.
[http://dx.doi.org/10.1016/S0140-6736(03)13490-3 PMID: 12788576]
[35]
Kirjavainen, P.V.; Arvola, T.; Salminen, S.J.; Isolauri, E. Aberrant composition of gut microbiota of allergic infants: A target of bifidobacterial therapy at weaning? Gut, 2002, 51(1), 51-55.
[http://dx.doi.org/10.1136/gut.51.1.51 PMID: 12077091]
[36]
Wang, I.J.; Wang, J.Y. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin. Exp. Allergy, 2015, 45(4), 779-787.
[http://dx.doi.org/10.1111/cea.12489] [PMID: 25600169]
[37]
Gerasimov, S.V.; Vasjuta, V.V.; Myhovych, O.O.; Bondarchuk, L.I. Probiotic supplement reduces atopic dermatitis in preschool children: A randomized, double-blind, placebo-controlled, clinical trial. Am. J. Clin. Dermatol., 2010, 11(5), 351-361.
[http://dx.doi.org/10.2165/11531420-000000000-00000 PMID: 20642296]
[38]
Wickens, K.; Black, P.N.; Stanley, T.V.; Mitchell, E.; Fitzharris, P.; Tannock, G.W.; Purdie, G.; Crane, J. Probiotic Study Group. A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol., 2008, 122(4), 788-794.
[http://dx.doi.org/10.1016/j.jaci.2008.07.011] [PMID: 18762327]
[39]
Wickens, K.; Black, P.; Stanley, T.V.; Mitchell, E.; Barthow, C.; Fitzharris, P.; Purdie, G.; Crane, J. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin. Exp. Allergy, 2012, 42(7), 1071-1079.
[http://dx.doi.org/10.1111/j.1365-2222.2012.03975.x PMID: 22702506]
[40]
Wickens, K.; Stanley, T.V.; Mitchell, E.A.; Barthow, C.; Fitzharris, P.; Purdie, G.; Siebers, R.; Black, P.N.; Crane, J. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: Does it also reduce atopic sensitization? Clin. Exp. Allergy, 2013, 43(9), 1048-1057.
[http://dx.doi.org/10.1111/cea.12154] [PMID: 23957340]

Rights & Permissions Print Cite
Article Metrics
42
1
© 2024 Bentham Science Publishers | Privacy Policy